Altimmune to Participate at Two Upcoming Investor

GAITHERSBURG, Md., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that...

Related Keywords

Richard Eisenstadt ,Danielle Cantey ,Linkedin ,Altimmune Inc ,Nasdaq ,Virtual Conference ,Annual Hepatitisb Virus ,Investor Contact ,Nasdaq Alt ,Altimmune ,Nc ,